Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:18:39.101Z.
Calculation as of: 2026-10-06T21:18:39.101Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76451fd983189bd376b55241b8a4b850ffcaa8def2b2c0e687122d8ae3ae7442
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Verrica Pharmaceuticals Inc.
Market Cap
$72.32M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$72.83M
Free Cash Flow Yield
N/A
TTM Avg
0.09%
3Y Avg
0.09%
5Y Avg
0.09%
Market Cap
$71.23M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70.63M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.61M
Free Cash Flow Yield
N/A
TTM Avg
6.20%
3Y Avg
5.62%
5Y Avg
4.88%
Market Cap
$68.90M
Free Cash Flow Yield
28.42%
TTM Avg
14.79%
3Y Avg
25.02%
5Y Avg
20.90%
Market Cap
$75.95M
Free Cash Flow Yield
21.91%
TTM Avg
19.39%
3Y Avg
7.46%
5Y Avg
7.46%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | $72.32M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | N/A | 0.09% | 0.09% | 0.09% |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | N/A | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | N/A | N/A | N/A | N/A |
| Tiziana Life Sciences Ltd (TLSA)vs › | $70.63M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | N/A | 6.20% | 5.62% | 4.88% |
| Pulmonx Corporation (LUNG)vs › | $75.18M | N/A | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 28.42% | 14.79% | 25.02% | 20.90% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | 21.91% | 19.39% | 7.46% | 7.46% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 184.79% | 137.42% | 137.42% | 137.42% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
